Moderate riskFDA DeviceClass II

Quidel QuickVue Dipstick Strep A Test recalled for false positive results

Certain lots of the Quidel QuickVue Dipstick Strep A Test may return false positive results, meaning the test could indicate a strep infection when one is not actually present. This could lead to unnecessary antibiotic treatment. The recall affects specific lot numbers distributed across the US.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if your test kit is from lot 225788, 228322, or 233274 (printed on the box).
  2. If you have an affected lot, do not use it. Contact your healthcare provider or Quidel for a replacement.
  3. If you used an affected test and received a positive result, confirm the diagnosis with your doctor before starting antibiotics.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.
Sold in
Nationwide
Made for
All ages (under 100 years)

Details

Units affected
12279 units
Illnesses reported
None reported
Manufactured in
10165 McKellar Ct, San Diego, CA, United States
Classification
Class II
Recall number
Z-2169-2026

In the FDA's words

Description
QuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp. Product has the potential for false positive results UDI/DI 30014613201083, Lot Numbers: 225788, 228322, 233274. Distribution: US Nationwide distribution in the states of AL, CA, FL, ID, IL, LA, MA, MD, MN, MO, NY, PA, SC, TN, TX, VA. Affected quantity: 12279 units
Hazard
Product has the potential for false positive results

Related topics